These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15390036)

  • 1. Hypertension and progressive supranuclear palsy: is everything so clear?
    Sibon I; Macia F; Vital A; Delacourte A; Tison F
    Mov Disord; 2004 Oct; 19(10):1259-61. PubMed ID: 15390036
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal cytological changes of progressive supranuclear palsy type in clinically possible progressive supranuclear palsy.
    Toru S; Uchihara T; Akashi T; Kobayashi T
    Eur Neurol; 2010; 63(2):122-5. PubMed ID: 20110714
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual and regional variations of phospho-tau species in progressive supranuclear palsy.
    Puig B; Rey MJ; Ferrer I
    Acta Neuropathol; 2005 Sep; 110(3):261-8. PubMed ID: 15973541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serial MRI study in a patient with progressive supranuclear palsy with cerebellar ataxia.
    Kanazawa M; Shimohata T; Endo K; Koike R; Takahashi H; Nishizawa M
    Parkinsonism Relat Disord; 2012 Jun; 18(5):677-9. PubMed ID: 22153384
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical progressive supranuclear palsy with corticospinal tract degeneration.
    Josephs KA; Katsuse O; Beccano-Kelly DA; Lin WL; Uitti RJ; Fujino Y; Boeve BF; Hutton ML; Baker MC; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):396-405. PubMed ID: 16691120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy-like phenotype associated with bilateral hypoxic-ischemic striopallidal lesions.
    Kim HT; Shields S; Bhatia KP; Quinn N
    Mov Disord; 2005 Jun; 20(6):755-7. PubMed ID: 15782420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient page. Progressive supranuclear palsy.
    Karceski S
    Neurology; 2008 Nov; 71(22):e70-2. PubMed ID: 19029512
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shunt responsive progressive supranuclear palsy?
    Schott JM; Williams DR; Butterworth RJ; Janssen JC; Larner AJ; Holton JL; Rossor MN
    Mov Disord; 2007 Apr; 22(6):902-3. PubMed ID: 17357140
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive supranuclear gaze palsy without parkinsonism: a case of neuro-Whipple.
    Magherini A; Pentore R; Grandi M; Leone ME; Nichelli PF
    Parkinsonism Relat Disord; 2007 Oct; 13(7):449-52. PubMed ID: 17071126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter correlates of behavioral severity in progressive supranuclear palsy.
    Josephs KA; Whitwell JL; Eggers SD; Senjem ML; Jack CR
    Mov Disord; 2011 Feb; 26(3):493-8. PubMed ID: 21462261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1997. A 64-year-old man with progressive dementia, seizures, and unstable gait.
    N Engl J Med; 1997 Aug; 337(8):549-56. PubMed ID: 9262500
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy.
    Favaretto S; Ferrari S; Battistin L; Cagnin A
    Parkinsonism Relat Disord; 2011 Nov; 17(9):708-9. PubMed ID: 21669546
    [No Abstract]   [Full Text] [Related]  

  • 19. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticobasal degeneration presenting with progressive spasticity.
    Hasselblatt M; Föllinger S; Steinbach P; Schwan A; Paulus W
    Neurology; 2007 Mar; 68(10):791-2. PubMed ID: 17339593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.